![No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | FiercePharma No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | FiercePharma](https://qtxasset.com/fiercepharma/1631128798/AJOVY%20Image.jpg/AJOVY%20Image.jpg?VersionId=1aTmJJpw6vsP4osA4cmNj3zhuzNAp_iC)
No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | FiercePharma
![Teva Pharmaceuticals on Twitter: "Migraine is not just a headache. Our migraine expert, Dr Joshua Cohen, explains why it's time to break the stigma. #MigraineandHeadacheAwarenessMonth https://t.co/rD3hXiRVoc https://t.co/b46jYhpZSH" / Twitter Teva Pharmaceuticals on Twitter: "Migraine is not just a headache. Our migraine expert, Dr Joshua Cohen, explains why it's time to break the stigma. #MigraineandHeadacheAwarenessMonth https://t.co/rD3hXiRVoc https://t.co/b46jYhpZSH" / Twitter](https://pbs.twimg.com/media/EbrnSX8X0AMJXTD.jpg)
Teva Pharmaceuticals on Twitter: "Migraine is not just a headache. Our migraine expert, Dr Joshua Cohen, explains why it's time to break the stigma. #MigraineandHeadacheAwarenessMonth https://t.co/rD3hXiRVoc https://t.co/b46jYhpZSH" / Twitter
![Showcasing Teva's Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache... | Business Showcasing Teva's Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache... | Business](https://mms.businesswire.com/media/20210830005127/en/739014/22/teva_RGB_JPEG.jpg)
Showcasing Teva's Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache... | Business
![Teva launches pre-filled pen for anti-CGRP migraine therapy AJOVY®▽ (fremanezumab) in the UK - ACNR | Paper & Online Neurology Journal ACNR | Paper & Online Neurology Journal Teva launches pre-filled pen for anti-CGRP migraine therapy AJOVY®▽ (fremanezumab) in the UK - ACNR | Paper & Online Neurology Journal ACNR | Paper & Online Neurology Journal](https://acnr.co.uk/wp-content/uploads/2020/09/teva-logo.png)